Fundamental Analysis of WINDTREE THERAPEUTICS INC(NASDAQ:WINT) stock

Fundamental Rating

WINT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 588 industry peers in the Biotechnology industry. WINT has a bad profitability rating. Also its financial health evaluation is rather negative. WINT has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year WINT has reported negative net income.

In the past year WINT has reported a negative cash flow from operations.

In the past 5 years WINT always reported negative net income.

WINT had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -68.78%, WINT is not doing good in the industry: 64.96% of the companies in the same industry are doing better.

WINT has a Return On Equity of -331.07%. This is in the lower half of the industry: WINT underperforms 76.75% of its industry peers.

		Industry Rank	Sector Rank
ROA	-68.78%
ROE	-331.07%
ROIC	N/A

ROA(3y)-74.15%

ROA(5y)-54.93%

ROE(3y)-200.11%

ROE(5y)-137.61%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

WINT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

WINT has more shares outstanding than it did 1 year ago.

The number of shares outstanding for WINT has been increased compared to 5 years ago.

The debt/assets ratio for WINT is higher compared to a year ago.

2.2 Solvency

WINT has an Altman-Z score of -33.79. This is a bad value and indicates that WINT is not financially healthy and even has some risk of bankruptcy.

The Altman-Z score of WINT (-33.79) is worse than 92.14% of its industry peers.

WINT has a Debt/Equity ratio of 2.07. This is a high value indicating a heavy dependency on external financing.

WINT has a worse Debt to Equity ratio (2.07) than 82.39% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	2.07
Debt/FCF	N/A
Altman-Z	-33.79

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

WINT has a Current Ratio of 2.41. This indicates that WINT is financially healthy and has no problem in meeting its short term obligations.

WINT has a Current ratio of 2.41. This is in the lower half of the industry: WINT underperforms 74.19% of its industry peers.

A Quick Ratio of 2.41 indicates that WINT has no problem at all paying its short term obligations.

WINT has a worse Quick ratio (2.41) than 72.31% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.41
Quick Ratio	2.41

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

WINT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 72.73%, which is quite impressive.

EPS 1Y (TTM)72.73%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q86.77%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Revenue growth Q2QN/A

3.2 Future

The Earnings Per Share is expected to grow by 9.68% on average over the next years. This is quite good.

The Revenue is expected to grow by 17.21% on average over the next years. This is quite good.

EPS Next Y-443.3%

EPS Next 2Y0%

EPS Next 3Y9.68%

EPS Next 5YN/A

Revenue Next Year-100%

Revenue Next 2Y-41.42%

Revenue Next 3Y17.22%

Revenue Next 5YN/A

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

WINT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for WINT. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y0%

EPS Next 3Y9.68%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for WINT!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

WINDTREE THERAPEUTICS INC

NASDAQ:WINT (4/19/2024, 12:13:34 PM)

0.3486

+0.01 (+2.59%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap3.20M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-68.78%
ROE	-331.07%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	2.07
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	2.41
Quick Ratio	2.41
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)72.73%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y-443.3%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

WINDTREE THERAPEUTICS INC (WINT)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens